Board of Directors
Ferran Prat
Chairman of the Board
Over 30 years in the Diagnostics and Pharma sector
Companies
VITRO Group, Werfen, LETI Pharma, DAKO
Education
Degree in Pharmacy from the University of Barcelona, Master’s in Marketing from EADA, and Master’s in Digital Transformation from IESE
Marta Barrachina
CEO
Co-Founder
Board Member
Principal Investigator at the Bellvitge Biomedical Research Institute for 17 years. CEO of the company since its inception
Education
PhD in Biochemistry from the University of Barcelona, and MBA from Ramon Llull University
Santiago Lozano
Board Member
Fund Director at Clave Capital
Education
Degree in Economics from the University of Navarra and Master’s in Financial Management (ESIC)
Maite Fibla
Board Member
Co-founder of the Ship2B Foundation and Director at Ship2B Ventures
Education
PhD in Economics
Howard Fillit
Board Member – Observer
Co-founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation. Geriatrician, neuroscientist, and Alzheimer’s disease expert. Member of the American Geriatrics Society, the American College of Physicians, the Gerontological Society of America, and the New York Academy of Medicine
Medical Advisory Board
Ramón Reñé
Co-Founder and Member of the Medical Advisory Board
Head of the Functional Dementia Unit at the Bellvitge University Hospital until retirement
PhD in Medicine and Surgery from the University of Barcelona
Jordi Gascón
Co-Founder and Member of the Medical Advisory Board
Head of Neurology at Bellvitge University Hospital (HUB), Deputy Director of Ambulatory and Hospitalization Area at HUB, and Associate Professor of Morphological Sciences at the Autonomous University of Barcelona
Degree in Medicine and Surgery from the Autonomous University of Barcelona
Scientific Advisory Board
Russell Swerdlow
Member of the Scientific Advisory Board
Professor in the Departments of Neurology, Cell Biology and Physiology, and Biochemistry and Molecular Biology at the University of Kansas School of Medicine
Recipient of the S. Weir Mitchell Award (American Academy of Neurology), the Cotzias Award (American Parkinson’s Disease Association), the Chancellor’s Club Research Award, the Dolph Simons Research Achievement Award in Biomedical Sciences (University of Kansas), and the Oskar Fischer Prize
Courosh Mehanian
Member of the Scientific Advisory Board
Affiliate Faculty at the Knight Campus for Accelerating Scientific Impact, University of Oregon, and Oregon Health and Science University in Portland; Principal Investigator at the Machine Learning Global Health Labs, Bellevue, Washington
Carlos Cruchaga
Member of the Scientific Advisory Board
Leader of the Neurogenomics and Informatics group at Washington University
Operational Team
Miguel Viribay
Business Development Director
PhD in Biochemistry from the Autonomous University of Madrid
Over 25 years of experience in the Life Sciences and Diagnostics sector (Applied Biosystems, Thermo, VITRO Group, etc.)
He has worked in Spain, the United Kingdom, and Portugal.
Marta Blanch
Laboratory Director
Expert in NGS methods. Oversees a CAP-accredited laboratory certified under ISO13485
PhD in Biochemistry and Molecular Biology from the University of Barcelona.
Jose Luis Mosquera
Director of Artificial Intelligence and Data Science Department
Specialist in Bioinformatics, AI/ML, and Omics
PhD in Statistics and Mathematics from the University of Barcelona
Víctor Fuentes
Quality Manager
Leads ISO compliance at the company
Extensive experience in manufacturing and medical devices in Europe and the UK
Industrial Engineer from the Universidad Polictécnica de Barcelona
Carla Trapero
Project Manager
Manages national and international multicenter projects
PhD in Biomedicine from the University of Barcelona, Master’s in Clinical Analysis, and Master’s in Project Management certified by the PMI
